Transaction overview
Acuren Corporation, a leading provider of tech-enabled Testing, Inspection, Certification, and Compliance (TICC) services in North America, completed its merger with NV5 Global, Inc. on August 4, 2025. The transaction valued NV5 at approximately $1.7 billion, marking Acuren’s acquisition of the entire outstanding equity stake in NV5. Under the deal terms, NV5 stockholders received $23.00 per share, consisting of $10.00 in cash and 1.1523 shares of Acuren Common Stock for each share of NV5 Common Stock.
Deal structure and financing
The merger's financial details were not publicly disclosed regarding the equity-debt split or lead banks involved. However, it is known that the deal included full repayment of NV5’s outstanding debt, implying a significant portion of the $1.7 billion enterprise value may have been covered through cash payments. The final exchange ratio was calculated based on the volume-weighted average price (VWAP) of Acuren's common stock over a 10-trading day period ended August 1, 2025, indicating an equity component valued at approximately $974 million and a cash payment of around $736 million. NV5’s stockholders are subject to certain lock-up provisions, preventing them from selling their shares for a period after the merger closing.
Strategic context
The strategic rationale behind this transaction lies in Acuren's ambition to become a dominant player in North American TICC and engineering services. By integrating with NV5, which offers extensive expertise in engineering and geospatial services, Acuren aims to expand its service offerings and diversify its client base across critical infrastructure sectors including energy, utilities, and government projects. The combination is expected to enhance cross-selling opportunities and drive long-term growth by leveraging complementary geographic footprints and customer relationships.
Regulatory path
The merger required regulatory approvals in multiple jurisdictions due to the deal’s substantial size. However, specific details on which regulators reviewed the transaction or any remedies imposed have not been disclosed publicly. Given the nature of the services involved and the geographical spread of operations, it is likely that both U.S. federal antitrust authorities and state-level agencies were consulted during the approval process. The HSR Act filing and EU filings, if applicable, would have taken place well before the closing date to ensure regulatory clearance.
The completion marks a significant milestone for both Acuren and NV5, establishing them as a leading provider of critical services in North America's infrastructure landscape.